RNA Polymerase Processes Synthetic DNA
Researchers at the University of California San Diego have proven that a primary biological enzyme can read and transcribe an expanded genetic alphabet. This eight-letter system doubles the four-letter code found in all known life on Earth. The findings demonstrate that cellular machinery handles synthetic genetic information with the same precision as natural DNA. Scientists believe this capability will unlock new ways to engineer biological systems for specific medical or industrial tasks.
Dong Wang, a professor at the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, led the research team. Their work centers on RNA polymerase, the enzyme that reads DNA to produce RNA. This process represents the starting point for gene expression in bacteria like E. coli. Using cryo-electron microscopy, the team captured high-resolution snapshots of the enzyme in action. These images show the molecular interactions at a scale smaller than a single atom. The data reveals that the enzyme recognizes synthetic letters through the same signals used for natural base pairs.
Insights from Microscopic Snapshots
The team performed biochemical experiments alongside their structural analysis. These tests confirmed that the enzyme faithfully transcribes the synthetic base pairs. In a separate study published on August 12, 2026, in PNAS, the same group identified that RNA polymerase can also handle synthetic pairs that lack hydrogen bonds. This further confirms the flexibility of the enzyme. The combination of these findings suggests that the biological mechanism for reading genetic data is more adaptable than previously thought.
This adaptability is not just a theoretical observation. It provides a roadmap for future biotechnology. By understanding how the enzyme incorporates these letters, researchers can design systems that create compounds impossible for standard nature to produce. The molecular foundation established here will likely influence how labs approach the construction of synthetic DNA molecules.
Future Directions for Synthetic Biology
Previous efforts have already deployed expanded genetic alphabets to create synthetic DNA capable of flagging liver cancer cells. This new research provides the necessary structural proof to refine those diagnostic tools. The ability to transcribe non-natural DNA opens doors for custom therapeutics and advanced biological diagnostics. Industry experts view this as a necessary step toward reliable synthetic systems.
What comes next involves testing these systems in more complex environments. The researchers have moved past the basic question of whether the enzyme can read the letters. They are now looking at how to maintain this expanded alphabet in living, replicating cells. The goal is a stable, self-perpetuating synthetic system that functions within a broader biological context. While challenges remain in long-term stability, this work removes a significant barrier to progress.
Scientists must now bridge the gap between in-vitro success and practical application. If cells can reliably maintain these eight letters, the potential for custom-engineered proteins grows significantly. Biotechnology firms are already keeping a close watch on these developments. The research published in Nature Communications on September 2, 2026, provides the baseline data for these future applications. It marks a shift from proof-of-concept experiments to the engineering phase of synthetic biology.